Metagenomi, Inc. Common Stock (MGX) vs Veru Inc. (VERU)
A side-by-side comparison of Metagenomi, Inc. Common Stock and Veru Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MGX
Metagenomi, Inc. Common Stock
$1.04HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
VERU
Veru Inc.
$2.50HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
Total return — MGX vs VERU
growth of $100 · dividends reinvested · last 3yMGX -89.9% (-53.4%/yr)VERU -42.0% (-16.6%/yr)VERU compounded faster over this window
Log scale — wide-divergence pair
MGX VERU
MGX vs VERU: by the numbers
- •VERU is the larger company ($40M vs $39M market cap).
- •Both run net losses; VERU's is the smaller (0.00% vs -689.20% net margin).
Metrics side by side
Valuation
| Metric | MGX | VERU |
|---|---|---|
| P/S ratio | 2.89 | N/A |
| P/B ratio | 0.35 | 1.41 |
Profitability
| Metric | MGX | VERU |
|---|---|---|
| Gross margin | 74.29% | 0.00% |
| Operating margin | -380.85% | 0.00% |
| Net margin | -689.20% | 0.00% |
| ROE | -83.03% | -47.96% |
| ROIC | -66.03% | -60.64% |
Growth (annualized)
| Metric | MGX | VERU |
|---|---|---|
| Total return CAGR (5Y) | N/A | -50.43% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.